Ontology highlight
ABSTRACT:
PROVIDER: PRJNA1203745 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR31842600_1.fastq.gz | Fastqsanger.gz | |||
| SRR31842600_2.fastq.gz | Fastqsanger.gz | |||
| SRR31842700_1.fastq.gz | Fastqsanger.gz | |||
| SRR31842700_2.fastq.gz | Fastqsanger.gz | |||
| SRR31842601_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 240 |
Similar Datasets
Project description:Gene expression data from acetaminophen-induced toxicity in human hepatic in vitro systems and clinical liver samples
2025-01-24 | E-GEOD-74000 | ExpressionAtlas
Project description:Intervention type:DRUG. Intervention1:Huaier, Dose form:GRANULES, Route of administration:ORAL, intended dose regimen:20 to 60/day by either bulk or split for 3 months to extended term if necessary. Control intervention1:None.
Primary outcome(s): For mRNA libraries, focus on mRNA studies. Data analysis includes sequencing data processing and basic sequencing data quality control, prediction of new transcripts, differential expression analysis of genes. Gene Ontology (GO) and the KEGG pathway database are used for annotation and enrichment analysis of up-regulated genes and down-regulated genes.
For small RNA libraries, data analysis includes sequencing data process and sequencing data process QC, small RNA distribution across the genome, rRNA, tRNA, alignment with snRNA and snoRNA, construction of known miRNA expression pattern, prediction New miRNA and Study of their secondary structure Based on the expression pattern of miRNA, we perform not only GO / KEGG annotation and enrichment, but also different expression analysis.. Timepoint:RNA sequencing of 240 blood samples of 80 cases and its analysis, scheduled from June 30, 2022..
| 2612481 | ecrin-mdr-crc
Project description:RNA-Sequencing of whole blood samples from children with a range of acute febrile illnesses
2025-01-23 | E-MTAB-11671 | ExpressionAtlas
Project description:In the current work, we present the first proteogenomic dataset of GBM clinical samples to date. We have assembled a cohort of 87 GBM patients of varying survival rates and performed MS-based proteomics analysis as well as RNA-seq in order to identify the molecular differences associated with survival and examine the contribution of each layer to GBM landscape. We show that each layer alone only partially reflects patient survival, but RNA-protein integration identifies clear patterns of layer-specific and layer-common processes specifically contributing to either short-term or long-term survival of patients. Furthermore, we compare our data to published single-cell RNA-seq of GBM tumors and evaluate the RNA-protein variability within single-cell based tumor subpopulations. We found that while all signatures of the four subpopulations tend to have high RNA-protein correlation, each signature is associated differently with survival. Altogether, these results highlight the potential of proteogenomics to further stratify heterogeneity in GBM tumors and identify processes contributing to poorer survival.
2021-04-16 | PXD018024 | Pride
Project description:Deep transcriptional sequencing analysis of human prostate adenocarcinoma and reference samples
2025-01-24 | E-GEOD-24283 | ExpressionAtlas
Project description:Here, by mapping H3K27ac deposition, we analyze the active regulatory landscapes across primary GBM biopsies, normal brain tissues, and cell line counterparts. Analysis of differentially regulated enhancers, especially super-enhancers between GBM and normal brain tissues, as well as among GBM samples with matched RNA-sequencing data, uncovered unrecognized layers of oncogenic core transcriptional dependency and inter-tumor heterogeneity. Moreover, we demonstrate the functional relevance of leading candidates of super-enhancer-driven transcriptional factors, long non-coding RNAs, and druggable targets in GBM. Through profiling of transcriptional enhancers, our integrative study provides clinically relevant insights into GBM molecular classification, pathogenesis, and therapeutic innovations.
2021-05-05 | GSE145644 | GEO
Project description:SWATH analysis of human kidney tissues to generate a digital map representing the proteome of biopsy level clinical samples.
2022-01-24 | E-PROT-59 | ExpressionAtlas
Project description:RNA-sequencing of coding RNA from human purified intestinal epithelial samples and organoids derived from foetal and paediatric small and large intestine
2025-01-23 | E-MTAB-5015 | ExpressionAtlas
Project description:RNA-seq samples of ten tissues for each of the 25 genomes of the Nested Associated Mapping (NAM) maize sequencing project
2024-11-17 | E-MTAB-8633 | ExpressionAtlas
Project description:Expression data from colonic biopsy samples of infliximab treated ulcerative colitis patients
2025-01-24 | E-GEOD-23597 | ExpressionAtlas